The Enterprise Value as of November 2024 (TTM) for Genprex, Inc. (GNPX) is 7.87M

According to Genprex, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.87M. This represents a change of 526.86% compared to the average of 1.26M of the last 4 quarters.

Genprex, Inc. (GNPX) Historical Enterprise Value (quarterly & annually)

How has GNPX Enterprise Value performed in the past?

The mean historical Enterprise Value of Genprex, Inc. over the last ten years is 35.42M. The current 7.87M Enterprise Value has changed 2.12% with respect to the historical average. Over the past ten years (40 quarters), GNPX's Enterprise Value was at its highest in in the March 2021 quarter at 149.12M. The Enterprise Value was at its lowest in in the March 2024 quarter at -3411655.00.

Genprex, Inc. (GNPX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genprex, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genprex, Inc. (GNPX) Average Enterprise Value

How has GNPX Enterprise Value performed in the past?

The current Enterprise Value of Genprex, Inc. (GNPX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genprex, Inc. (GNPX) Enterprise Value vs. Peers

How is GNPX’s Enterprise Value compared to its peers?

Genprex, Inc.’s Enterprise Value is less than Reviva Pharmaceuticals Holdings, Inc. (33.37M), less than Greenwich LifeSciences, Inc. (172.29M), greater than Cognition Therapeutics, Inc. (-3660922.00), less than Gracell Biotechnologies Inc. (5.61B), less than Reviva Pharmaceuticals Holdings, Inc. (33.37M), less than Eyenovia, Inc. (15.12M), greater than TransCode Therapeutics, Inc. (4.92M), less than Kodiak Sciences Inc. (201.31M), less than eFFECTOR Therapeutics, Inc. (0), greater than X4 Pharmaceuticals, Inc. (4.74M), less than Elevation Oncology, Inc. (38.44M), less than Mereo BioPharma Group plc (18.49M), less than Hepion Pharmaceuticals, Inc. (496.22M), greater than null (5.35M),

Build a custom stock screener for Genprex, Inc. (GNPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genprex, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genprex, Inc. (GNPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genprex, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.